Tanjala T Gipson1, Eboni I Lance2, Rebecca A Albury3, Maura B Gentner3, Mary L Leppert1. 1. Kennedy Krieger Institute, Baltimore, MD, USA Johns Hopkins University School of Medicine, Baltimore, MD, USA. 2. Kennedy Krieger Institute, Baltimore, MD, USA Johns Hopkins University School of Medicine, Baltimore, MD, USA lance@kennedykrieger.org. 3. Kennedy Krieger Institute, Baltimore, MD, USA.
Abstract
AIMS: This study explores disparities in identification of educationally relevant comorbidities and medication prescribing practices for children with attention-deficit hyperactivity disorder (ADHD) and either comprehensive neurodevelopmental evaluations or evaluations limited by insurance to behavior management with medication. METHODS: This study was a retrospective chart review of 5- to 10-year-old children with ADHD diagnosed at the initial evaluation. Data collected included demographics, rates of comorbid conditions, medication management, and educational interventions. RESULTS: The 2 groups were similar in age, educational supports, and medication management. The group with insurance permitting comprehensive evaluations was more likely to be Caucasian, have higher parental education levels, and have more comorbid conditions identified with academic impact. CONCLUSIONS: School-aged children with ADHD are likely to receive similar educational and medication management despite differences in evaluations. However, our data suggest that children who received comprehensive evaluations had greater identification of comorbid conditions that may influence academic, behavioral, and social outcomes.
AIMS: This study explores disparities in identification of educationally relevant comorbidities and medication prescribing practices for children with attention-deficit hyperactivity disorder (ADHD) and either comprehensive neurodevelopmental evaluations or evaluations limited by insurance to behavior management with medication. METHODS: This study was a retrospective chart review of 5- to 10-year-old children with ADHD diagnosed at the initial evaluation. Data collected included demographics, rates of comorbid conditions, medication management, and educational interventions. RESULTS: The 2 groups were similar in age, educational supports, and medication management. The group with insurance permitting comprehensive evaluations was more likely to be Caucasian, have higher parental education levels, and have more comorbid conditions identified with academic impact. CONCLUSIONS: School-aged children with ADHD are likely to receive similar educational and medication management despite differences in evaluations. However, our data suggest that children who received comprehensive evaluations had greater identification of comorbid conditions that may influence academic, behavioral, and social outcomes.
Authors: Mark Wolraich; Lawrence Brown; Ronald T Brown; George DuPaul; Marian Earls; Heidi M Feldman; Theodore G Ganiats; Beth Kaplanek; Bruce Meyer; James Perrin; Karen Pierce; Michael Reiff; Martin T Stein; Susanna Visser Journal: Pediatrics Date: 2011-10-16 Impact factor: 7.124
Authors: Timothy E Wilens; Joseph Biederman; Sarah Brown; Sarah Tanguay; Michael C Monuteaux; Christie Blake; Thomas J Spencer Journal: J Am Acad Child Adolesc Psychiatry Date: 2002-03 Impact factor: 8.829
Authors: Jeffrey H Newcorn; Scott R Miller; Iliyan Ivanova; Kurt P Schulz; Jessica Kalmar; David J Marks; Jeffrey M Halperin Journal: CNS Spectr Date: 2004-09 Impact factor: 3.790
Authors: Kelly Posner; Glenn A Melvin; Desiree W Murray; S Sonia Gugga; Prudence Fisher; Anne Skrobala; Charles Cunningham; Benedetto Vitiello; Howard B Abikoff; Jaswinder K Ghuman; Scott Kollins; Sharon B Wigal; Tim Wigal; James T McCracken; James J McGough; Elizabeth Kastelic; Roy Boorady; Mark Davies; Shirley Z Chuang; James M Swanson; Mark A Riddle; Laurence L Greenhill Journal: J Child Adolesc Psychopharmacol Date: 2007-10 Impact factor: 2.576